A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 3 692,18 Kč, with a 24-hour trading volume of 4,78B Kč. The asset's market cap is 5,72T Kč, after moving -0.19% in the last day.
Tokenized AstraZeneca PLC is trading at 2 065,89 Kč, with a tokenized market cap of 1,16B Kč and a 24-hour trading volume of 15,04M Kč. The tokenized asset has moved -3.12% in the past 24 hours.